Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 1
1997 1
1998 2
1999 2
2000 2
2001 6
2002 7
2003 12
2004 12
2005 8
2006 7
2007 4
2008 1
2009 7
2010 5
2011 6
2012 5
2013 4
2014 2
2015 3
2016 3
2017 5
2019 3
2020 5
2021 1
2022 4
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 22952326

109 results

Results by year

Filters applied: . Clear all
Page 1
Interferon beta for secondary progressive multiple sclerosis.
La Mantia L, Vacchi L, Di Pietrantonj C, Ebers G, Rovaris M, Fredrikson S, Filippini G. La Mantia L, et al. Cochrane Database Syst Rev. 2012 Jan 18;1:CD005181. doi: 10.1002/14651858.CD005181.pub3. Cochrane Database Syst Rev. 2012. PMID: 22258960 Review.
Benefit of interferon beta-1a on MSFC progression in secondary progressive MS.
Cohen JA, Cutter GR, Fischer JS, Goodman AD, Heidenreich FR, Kooijmans MF, Sandrock AW, Rudick RA, Simon JH, Simonian NA, Tsao EC, Whitaker JN; IMPACT Investigators. Cohen JA, et al. Neurology. 2002 Sep 10;59(5):679-87. doi: 10.1212/wnl.59.5.679. Neurology. 2002. PMID: 12221157 Clinical Trial.
Interferon beta-1b in secondary progressive MS: a combined analysis of the two trials.
Kappos L, Weinshenker B, Pozzilli C, Thompson AJ, Dahlke F, Beckmann K, Polman C, McFarland H; European (EU-SPMS) Interferon beta-1b in Secondary Progressive Multiple Sclerosis Trial Steering Committee and Independent Advisory Board; North American (NA-SPMS) Interferon beta-1b in Secondary Progressive Multiple Sclerosis Trial Steering Committee and Independent Advisory Board. Kappos L, et al. Neurology. 2004 Nov 23;63(10):1779-87. doi: 10.1212/01.wnl.0000145561.08973.4f. Neurology. 2004. PMID: 15557490
Multicentre, randomised, double blind, placebo controlled, phase III study of weekly, low dose, subcutaneous interferon beta-1a in secondary progressive multiple sclerosis.
Andersen O, Elovaara I, Färkkilä M, Hansen HJ, Mellgren SI, Myhr KM, Sandberg-Wollheim M, Soelberg Sørensen P. Andersen O, et al. J Neurol Neurosurg Psychiatry. 2004 May;75(5):706-10. doi: 10.1136/jnnp.2003.010090. J Neurol Neurosurg Psychiatry. 2004. PMID: 15090564 Free PMC article. Clinical Trial.
109 results